コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 associated with TGs, total cholesterol, and non-high-density lipoprotein cholesterol.
2 es of low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol.
3 ortality, provides significant reductions in non-high-density lipoprotein cholesterol.
4 .4%]), and combined hypertension, LDL-C, and non-high-density lipoprotein cholesterol (1.8% [95% CI,
5 ity lipoprotein cholesterol (27.9 to 60.0%), non-high-density lipoprotein cholesterol (10.0 to 36.6%)
6 pg/mL), higher mean fasting serum levels of non-high-density lipoprotein cholesterol (126.5 and 121.
7 otal cholesterol (-24.8 mg/dl), atherogenic (non-high-density lipoprotein) cholesterol (-19.9 mg/dl),
8 h-density lipoprotein-cholesterol, 12.0% for non-high-density lipoprotein-cholesterol, 8.0% for low-d
9 ol, high-density lipoprotein cholesterol, or non-high-density lipoprotein cholesterol, although trigl
10 olate diet for 3 mo had a 3-fold decrease in non-high-density lipoprotein cholesterol and a trend tow
11 cribed for LDL-C were observed with achieved non-high-density lipoprotein cholesterol and apolipoprot
12 educational attainment, exercise, levels of non-high-density lipoprotein cholesterol and high-sensit
13 y 1.6% or 1.4% after adjustment for LDL-C or non-high-density lipoprotein cholesterol and other covar
14 d the relationship between additional LDL-C, non-high-density lipoprotein cholesterol, and apolipopro
16 y lipoprotein, high-density lipoprotein, and non-high-density lipoprotein cholesterol, and triglyceri
17 SAR236553 also substantially reduced non-high-density lipoprotein cholesterol, apolipoprotein
18 ces were also observed in total cholesterol, non-high-density lipoprotein cholesterol, apolipoprotein
19 atin therapy have demonstrated reductions in non-high-density lipoprotein cholesterol as well as low-
20 ent for other cardiac risk factors including non-high-density lipoprotein cholesterol at 55 years of
21 a cholesterol (by 40 and 57%, respectively), non-high density lipoprotein cholesterol (by 48 and 61%,
22 fat diet for 10 wk showed a 40% increase in non-high-density lipoprotein cholesterol, consistent wit
23 ed with concomitant hypertension, LDL-C, and non-high-density lipoprotein cholesterol control (odds r
24 s on low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol goals in second
25 between duration of moderate hyperlipidemia (non-high-density lipoprotein cholesterol >/= 160 mg/dL)
27 nged exposure to even moderate elevations in non-high-density lipoprotein cholesterol have elevated r
28 ncluded the triple goals of LDL-C <70 mg/dl, non-high-density lipoprotein cholesterol (HDL-C) <100 mg
29 iscordance between population percentiles of non-high-density lipoprotein cholesterol (HDL-C) and low
30 lycerides are >200 mg/dl, the measurement of non-high-density lipoprotein cholesterol (HDL-C) is reco
32 low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (HDL-C), and ap
33 able effects on total plasma cholesterol and non-high-density lipoprotein cholesterol in KO, Het, and
34 terol, high density lipoprotein cholesterol, non-high density lipoprotein cholesterol, insulin, or bo
36 al trials have examined the relation between non-high-density lipoprotein cholesterol level and cardi
37 -C of at least 70 mg/dL or a final screening non-high-density lipoprotein cholesterol level of at lea
39 tions in total, low-density lipoprotein, and non-high-density lipoprotein cholesterol levels, in trig
40 ficantly reduced levels of apolipoprotein B, non-high-density lipoprotein cholesterol, lipoprotein(a)
41 dl for remnant cholesterol, and -8 mg/dl for non-high-density lipoprotein cholesterol; lipoprotein(a)
42 evels of total, low-density lipoprotein, and non-high-density lipoprotein cholesterol; lower levels o
43 lar events and control of 6 RFs (no smoking, non-high-density lipoprotein cholesterol <130 mg/dl, tri
45 Education Program guidelines recommend that non-high-density lipoprotein cholesterol (non-HDL-C) be
46 n and low-density lipoprotein (LDL), whereas non-high-density lipoprotein cholesterol (non-HDL-C) lev
47 tein cholesterol (LDL-C), triglycerides, and non-high-density lipoprotein cholesterol (non-HDL-C) pre
49 low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), an
50 s but also LDL-related biomarkers, including non-high-density lipoprotein cholesterol (non-HDL-C), ap
52 oremost markers, apolipoprotein B (apoB) and non-high-density lipoprotein cholesterol (non-HDL-C), as
53 l youths, mean serum total cholesterol (TC), non-high-density lipoprotein cholesterol (non-HDL-C), hi
54 low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), hi
55 low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), or
56 is related to on-treatment apolipoprotein B, non-high-density lipoprotein cholesterol (non-HDL-C), tr
57 w-density lipoprotein cholesterol (LDL-C) or non-high-density lipoprotein cholesterol (non-HDL-C).
58 es, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol of, respectivel
59 sterol, low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or low-density
60 rapy to decrease low-density lipoprotein and non-high-density lipoprotein cholesterol to specific tar
61 Plasma of PLSCR3(-/-) mice was elevated in non-high-density lipoproteins, cholesterol, triglyceride
62 n significantly greater reductions in LDL-C, non-high-density lipoprotein cholesterol, triglycerides,
63 density lipoprotein cholesterol (LDL-C), and non-high-density lipoprotein cholesterol; values below d
64 e US National Cholesterol Education Program, non-high-density lipoprotein cholesterol was introduced
65 cholesterol, CRP, apolipoprotein B-100, and non-high-density lipoprotein cholesterol were related to
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。